Stryker Hip Implant Question?
Hip Replacement Implant Recall Lawsuit Attorney
Depuy Hip Replacement Biomet Magnum Zimmer Durom Wright Medical Smith & Nephew Hip Implant Recall
Hip Replacement Recall Implant Pages Direct Links
Stryker Rejuvenate Hip Implant Recall
DePuy ASR Hip Replacement Implant Recall
Biomet Magnum Hip Replacement Implant Recall
Zimmer Durom Hip Replacement Implant Recall
DePuy Pinnacle Hip Replacement Implant Recall
Wright Conserve Cup Hip Replacement Implant Recall
Smith & Nephew R3 Hip Replacement Implant Recall
DePuy ASR Hip Implant Settlement Lawsuit
After weeks of details being released about the multi billion dollar settlement offer in the Johnson & Johnson DePuy ASR Hip Implant Litigation, the full written settlement agreement has now been released.
The Settlement offer provides for a base payment of $250,000 for one revision surgery to remove an ASR hip implant. It provides for an additional $250,000 if bilateral ASR implants needed to be removed or if a revision on one side fails again and a re-revision is necessary
All medical bills and medical health insurance liens and Medicare liens will be paid outside of the settlement so those amounts do not need to be deducted from the ASR implant patient’s recovery.
There are adjustments to the base payment based upon length of time the implant was in place and body weight. There is also an extraordinary injury fund that will pay additional amounts for complications from the revision surgery such as pulmonary embolism, deep vein thrombosis, dislocation, foot drop, infection after revision, heart attack, stroke or death after revision, and extraordinary out of pocket loss of wages or income due to revision surgery.
DePuy has a right to walk away from the settlement if more than 6% of those eligible elect to reject the settlement and go on to trial in court on their legal cases.
Payments under this agreement would be made in the summer of 2014.
Johnson and Johnson will pay more than $4 billion to resolve DePuy ASR lawsuits
Johnson & Johnson will pay more than $4 billion to resolve more than 12,000 lawsuits in federal and state courts over defective DePuy ASR hip implants. Once approved, this settlement will be the largest US settlement of legal claims for a medical device, dwarfing the 2001 settlement of claims involving defective Sulzer hip and knee implants that cost $1 billion.
We expect the announcement will be made next week in federal court in Toledo, Ohio, where U.S. District Judge David Katz coordinates federal litigation. Judge Katz must approve the settlement.
DePuy recalled 93,000 ASR hip implants worldwide in August 2010, citing a 12 percent failure rate in the first five years. However, internal J&J documents show 37 percent of ASR hips failed after 4.6 years. In 2012, the failure rate in Australia rose to 44 percent within seven years. Unfortunately this is a poor prognosis for any recipient of a DePuy ASR hip system.
We expect that Judge Katz will approve the settlement and that 94 percent of eligible claimants will sign up warding off a DePuy withdrawal from the deal. There will be a timeframe within which clients will decide whether or not to participate in the settlement. Clients will have the opportunity to “opt out” and continue their litigation in court. It is expected that payments to individuals with one revised hip will be between $300,000 and $350,000. Individuals with bilateral revisions or those who suffered complications during revision or re-revisions will receive more money. The settlement will probably be scaled based upon age so a person with a revision who is 40 years old will receive more than someone who is 80 years old. We expect that those who have an ASR hip that has not been revised will not receive a substantial amount but that the settlement will remain open to pay them if their hip fails in the future and a revision is needed.
A California DePuy ASR hip implant case that had been set for jury trial on October 15, 2013 was settled for a confidential amount this week. This is likely to be the first substantial settlement of a Johnson & Johnson DePuy ASR hip implant case.
This California lawsuit is the fourth known settlement of an ASR case. The first three settlements were a year ago and were settled for $600,000 for all three or about $200,000 each. Most attorneys involved in this litigation believe that those first three settlements were too low and would not settle cases at that level. Bloomberg News reported last month that Johnson & Johnson was considering a 3 billion dollar settlement proposal for the 12,000 lawsuits now pending. This would roughly be about $300,000 per case where a revision surgery was needed as a result of a failed him implant.
The first ASR implant trial was a California case in which the jury awarded over 8 million dollars. The second and only other ASR case to be tried tool place in Chicago and the verdict was zero.
The next scheduled DePuy ASR jury trial is in Florida state court. It is currently set for November 8, 2013 in Palm Beach. The first Federal DePuy ASR hip implant trial was scheduled to start in September and was postponed twice and has not been reset.
The DePuy ASR was on the market from 2005-2010 when it was recalled because of injury from the metal in the implants leaching into the patient’s tissue causing a condition called metallosis.
So far DePuy and Johnson & Johnson have not offered a global settlement option for hip implant patients who would rather settle than go to trial. Eventually, they will have to do this because they cannot try 12,000 lawsuits defending a recalled and failed product.
Stryker Rejuvenate Hip Implant Recall
In July 2012, Stryker issued a recall of its Rejuvenate and ABGII hip replacement systems. The implant has been found to be prone to corrosion, joint dislocation, and the release of metal ions which can cause metallosis, tissue inflammation and necrosis.
More than 30,000 of the Stryker hip systems have been installed worldwide, 20,000 of them in U.S. patients. The failure of the implant has so far led to over 100 lawsuits being filed against Stryker in Bergen, N.j., where the company’s headquarters are located.
The Stryker Rejuvenate and ABGII hip prosthesis recall are part one of the more serious medical device failures in recent history. Most of the current hip recalls and failures such as the DePuy ASR are metal on metal hips. The Stryker Rejuvenate does not have a metal interface between the ball and the cup. The Rejuvenate causes an injury similar to the metal on metal hips but the metal debris is caused by micro motion of the metal joints that connect the stem in the femur to the ball in the hip system. The DePuy A.S.R. was the first to be recalled in 2010. Since then the Smith & Nephew R3 and the Zimmer Durom Cup have also been recalled. Metal-on-metal joints still on the market such as the Biomet Magnum, the Encore and the Wright Profemur Converse, Dynasty and Lineage are also failing at unacceptably high rate.
Read More By Clicking Here ............
Depuy Hip Replacement Recall Implant Recall
Los Angeles Jury Hits DePuy Orthopedics for $8.3 Million in First ASR Hip Implant Verdict
Today, a jury returned the first verdict in the DePuy ASR hip implant recall litigation. Jurors were critical of DePuy for leaving the product on the market for years after DePuy knew that the ASR was demonstrating an unacceptably high failure rate. The jury also found that the DePuy ASR was a defective product.
The $8.3 million dollar verdict included $338,136 in damages for medical expenses and $8 million for physical pain and suffering. DePuy had recalled the product in 2010 because it was defective but argued at the trial that the plaintiff Loren “Bill” Kransky had health conditions that caused the product to fail and that DePuy was not responsible for the failure of his ASR hip implant.
DePuy is making that same argument in over ten thousand other lawsuits against the company. In each case DePuy is trying to blame the failure of the ASR implant on the patient’s medical condition or lifestyle. DePuy is refusing to pay the jury assessed amount and will ask the judge to throw the verdict out. If the judge sustains the verdict then DePuy says that it will appeal the verdict. It is unlikely that Mr. Kransky will see any financial recovery soon from this verdict.
This verdict is good news for all of the other ASR implant patients with lawsuits pending because it will put pressure on DePuy to finally make some settlement offers in these cases. Mr. Kransky did have a complicated medical history that could be terminal for him in the near term and that is why he got an early trial date.
The Kransky case is particularly encouraging for others with lawsuits against DePuy and Johnson & Johnson because the jury was able to see through DePuy’s effort to blame his hip failure on his complicated medical condition and to see the truth: that the DePuy ASR failed because it was a bad product. Is should be easier for most plaintiffs who don’t have the unrelated medical complications that Mr. Kransky had to prove that the failure of their own hip implants were due to the defects in the product.
There are a number of other jury trials set against DePuy for the ASR recall. The next trial will start next week in Chicago. In the long run, I think the justice system will hold DePuy and Johnson & Johnson accountable to pay fair compensation to hip implant patients who are suffering from this terrible product.
Many DePuy ASR XL hip implant patients are suffering
from metal toxicity from Chromium and Cobalt debris
from their metal on metal hip implants. The excess wear
from the metal on metal in these poorly designed hip
implants is causing metal debris to be released into
the tissues of the hip around the implant. The toxicity
or poison from the chromium and cadmium debris released
into the body can cause necrosis or death of the
tissue. It can also damage the nerves and bone. The
medical literature has reflected concerns for a number
of years about metal on metal hip implants causing
toxic metal debris to be released in the body. However,
most other metal on metal implants do not have the
design problem of the DePuy that causes excessive wear
and unusually high releases of metal debris. It is
possible that most or maybe even all of the DePuy ASR
hip implants will have to be removed or replaced. The
metal toxicity can cause substantial damage if allowed
The DePuy implants are designed and marketed for
active people who need a wide range of motion so those
patients are likely to be younger and could suffer
exposure to the metal toxicity for many years. Metal
toxicity has been shown to cause cancer and brain
damage in industrial exposures but not yet in hip
implant cases. It will take many years to determine
whether there is a risk of these conditions from the
DePuy hip replacement implants made by Johnson &
Johnson. Patients with bilateral implants which are hip
implants on both sides would be exposed to twice the
amount of metal toxicity.
The individual lawsuits and class action lawsuits
that are being filed are alleging that Johnson &
Johnson the parent company of DePuy should have
recalled the DePuy ASR much earlier and that the
company was negligent for continuing to sell the hip
implants when they knew that they were dangerous and
that there was a high failure rate. The hip implant
registry in Australia has documented that DePuy ASR has
twice the failure rate of other hip implants used in
that country for several years. The U.S. does not have
a registry to keep track of hip implant failures. Any
hip replacement patient with a Johnson & Johnson
DePuy ASR hip implant should get legal advice now
because even if there are no symptoms now there is a
substantial risk of injury from these implants and
there is a limited time to file a lawsuit for
compensation. Johnson & Johnson's medical device
division has issued a worldwide recall of Johnson &
Johnson DePuy Orthopaedic hip implant devices because
of complaints it has received concerning the failure of
two systems of artificial hip implants.
The complaints relate to a high rate of revision
surgeries in patients who've had the DePuy ASR hip
parts implanted. The company has advised patients with
the DePuy hip implant parts to contact their physician
to review the functionality of the artificial Johnson
& Johnson DePuy Orthopaedic ASR model hip implants.
Complaints about the DePuy Orthopaedic ASR model hip
implants are not new. Patients began experiencing
problems with their DePuy hip implants as early as 2008
with many of those patients requiring complicated and
painful revision surgeries.
Complaints mounted during that time with patients
suffering from loosening parts, infections, fractures,
dislocation, sensitivity to metal and pain. DePuy has
revealed that its own internal data shows that the hip
replacement devices show a 12% rate of revision surgery
for the resurfacing system and a 13% rate for the ASR
XL system. In a separate action, the FDA had recently
sent a warning letter to DePuy Orthopaedics regarding
the marketing of different joint replacement parts
without prior FDA approval. The DePuy hip failures come
after other artificial hip devices, namely Stryker and
Zimmer hip implants have also experienced higher than
acceptable failure rates. Johnson & Johnson DePuy
Hip Implant Lawsuit
From Our Blog:
Risk of Cobalt Poisoning from DePuy ASR Hip
One of the reasons for the DePuy ASR hip implant recall
was the risk of Cobalt poisoning. The friction from the
poorly designed DePuy hip implant metal ball rubbing on
the cup in the hip replacement causes wear on the metal
parts. This wear creates metal shavings that get
deposited in the hip socket as well as the surrounding
tissues. This metal poisoning is called metallosis.
Symptoms of metallosis include: groin or thigh pain,
intense pain at the site of the hip replacement,
instability, and effusion (fluid filled mass). This can
cause death of the tissue called necrosis and
deterioration of the bone called osteolysis.
The DePuy ASR Hip Implant is made of chromium and
cobalt. Recent medical studies have shown that high
cobalt levels can cause serious adverse health effects
in metal on metal hip implant patients. A study by
Hogan in 2010 documented symptoms of cobalt poisoning
to include: visual impairment, cardiomyopathy,
hypothyroidism, cognitive impairment, auditory
impairment, peripheral neuropathy, and rashes.
Surgeons removing metal on metal hip implants have seen
visible damage to the tissues from the metal toxicity.
Metal poisoning from the hip implants can also cause
pseudotumors. A pseudotumor is a granulomatous mass or
lesion. These tumors are not cancer but can cause pain,
dislocation, nerve palsy and a noticeable lump.
As a result of the risk of injury from the metal
exposure by the DePuy Hip Replacement, the
manufacturer, Johnson & Johnson, has instituted an
intensive campaign to retrieve the explanted (removed)
DePuy ASR implants to test them. Johnson & Johnson
has sent written scripts to doctors offices to tell
their staffs what to say to hip implant patients.
Johnson & Johnson has attempted to get recalled hip
implant patients to give them medical authorizations to
get the patients medical records.
While it is important for any manufacturer to
investigate a product that they have sold that is
defective and is injuring consumers many lawyers for
patients believe that Johnson & Johnson is
overstepping its bounds in an effort to defend itself
against class action lawsuits and individual lawsuits.
For example, the protocol that Johnson & Johnson
has adopted for retrieval and testing of the implants
that have been removed provide that the implants should
be cleaned of all human tissue after they are removed
and before they are shipped to a testing lab to test
for wear of the devices. Attorneys for injured hip
implant patients believe that it is important to test
the tissues that are removed along with the implants in
order to establish the level of toxicity of cobalt in
the patients tissue. The Johnson & Johnson
protocols that involve destroying that tissue may
prevent injured patients from proving that they
received toxic cobalt exposures to the tissues in their
This is very important in a legal case because an
injured patient bringing a claim in court will have to
prove the dosage level of the exposure in order to
prove that the cobalt in the hip implant is responsible
for many types of injuries. Johnson & Johnson has
already denied that exposure levels are high enough to
cause injury in every lawsuit that has been filed even
before they have investigated the cases.
There has already been one hearing in court in which
lawyers have objected to Johnson & Johnson
contacting patients directly to get their medical
records. Every patient with a DePuy ASR Hip should get
legal advice immediately even if they do not have any
symptoms. Johnson & Johnson has a legal team in
place now that is working every day to deny and defend
all lawsuits that are filed.
The symptoms and illnesses from cobalt poisoning may
not be show up for long periods of time and it may be
too late to bring the claim or properly investigate if
legal advice is not sought until the injuries cause a
Depuy Hip Recall
Hip Replacement Recall
Hip Implant Recall
& Johnson DePuy Hip Replacement Implant Recall
Consumer Justice Attorney Alert:
Johnson & Johnson DePuy Hip Implant
on Metal Hip Replacement Recall Information
Hip Implant Hip Replacement Recall Depuy Biomet Stryker
Stryker Rejuvenate Stryker ABG II Hip Replacement Implant Neck Stem
Stryker Orthopaedics has recalled two devices that are used with hip implant devices in paitents undergoing hip replacement surgery.
This recall comes on the heels of multiple reports of problems or adverse events related to complications or defects with both the Stryker Rejuvenate Modular Neck Stem as well as the Stryker ABG II Modular Neck Stem. Patients have reported tissue swelling and pain related to both hip implant components.
The biotech division of Stryker Corporation based in Hopkinton, Mass has agreed to remove both the Rejuvenate Hip Implant Stem and the ABG II Hip Implant Replacement Stem from the market and discontinue distribution of both devices worldwide.
Adverse events as reported by the FDA related to these hip implant components are being investigated by our firm.
We encourage you to contact us with any questions and to seek justice for your situation.
Vaginal Mesh Lawsuit Attorney
Mesh Implant Recall Vaginal Surgery Mesh Recall
A new FDA study indicates that the Johnson &
Johnson mesh or transvaginal mesh as well as those made
by Bard and used in female surgeries for pelvic organ
prolapse (POP) and stress urinary incontinence (SUI)
may cause permanent injury to women rather than
benefiting them. The FDA report documents show that
serious injuries from the transvaginal mesh are not
uncommon and that the mesh products do not improve
surgical outcomes. Surgeries for pelvic organ prolapse
and stress urinary incontinence that were performed
without using the mesh had better outcomes. Women whom
have had the mesh implanted have also been burdened
with multiple follow up surgeries .
Medical device manufacturers whom promoted these
surgical mesh devices to doctors around the world for
use in surgeries, failed to conduct sufficient clinical
testing of these mesh products to insure that they were
both safe and beneficial. A very dangerous aspect of
these mesh assisted surgeries is that once the
transvaginal mesh has been implanted , it is for the
most part impossible to remove.
The lawsuits that we are filing are to prove that
the manufacturing corporations were negligent in
marketing the transvaginal mesh without proper clinical
testing and without disclosing to the doctors or the
women involved that these mesh products and mesh kits
had a substantial risk of serious permanent painful
injuries and offered no benefit in improved surgical
outcomes over surgeries without using the mesh.
judges have consolidated these vaginal mesh lawsuits
against Johnson & Johnson and against Bard in
separate proceedings. Johnson & Johnson and Bard
are the primary manufacturers of the vaginal mesh
products. Each lawsuit is an individual case and it is
unlikely that there will be a class action lawsuit
certified. The consolidated proceedings for discovery
allow each case to proceed on its own after preliminary
proceedings. Therefore, each person injured should
bring an individual case to protect the rights that
they have against the manufacturers.
Click Here For More Information About Transvaginal Mesh Defects
Zimmer Durom Hip Cup Implant
Consumer Justice Attorney Alert:
Zimmer Durom HipCup Implant
or Contact Us For Help
New 2010 Study: Zimmer Durom Cup Hip Implant Failure
A new study published in The Journal of Arthroplasty
in September 2010 provides additional information on
the failures of the Zimmer Durom Cup Hip Implant.
Zimmer suspended sales of this implant in August of
2008 after reports by surgeons of high failure rates.
Zimmer tried to blame the doctors' techniques for the
failures and resumed selling the implants after a few
months and after offering a training program for
surgeons. Few surgeons were willing to continue using
the products after the reports of the failures and the
Zimmer Durom Cup was quietly removed from the market
completely in 2010.
There have been hundreds of product liability
lawsuits against Zimmer over the defective design of
the Durom Cup. We believe that the problem with the
Durom Cup is the poor design of the product and not any
fault of the doctors.
In the 2010 medical article, Large-Head
Metal-on-Metal Total Hip Arthroplasty Using the Durom
Acetabular Component at Minimum 1-Year Interval by
Richard L. Illgen II, MD, John P. Heiner, MD, Matthew
W. Squire, MD, MS, and David N. Conrad, MD, the authors
compared 100 patients with Zimmer Durom Cup implants to
100 patients with Zimmer Trilogy implants and followed
them for one year. There were no failures in the
patients with the Zimmer Trilogy but 11% of the Zimmer
Durom Cup implants failed.
In the group of Zimmer Durom Cup patients that
failed and needed revisions (another surgery to put in
another hip implant) the doctors found that there was
no significant bone ingrowth into the Durom cups. The
bone ingrowth is necessary for the cups to stay in
position and to function properly.
The authors of the study did not find any patient or
surgical factors to account for the failures of the
Durom cups. Consequently, the problem is with the
design of the Durom cup not with the doctors as Zimmer
The recent publicity about the recall of the DePuy
ASR Hip Implant has prompted many hip implant
recipients with continuing pain and limitation of
motion to investigate the brand of their implants. More
Zimmer Durom Cup implant recipients have been coming
forward and contacting our office to report failures of
their Durom Cup implants when they discover that their
implant is a Durom Cup.
On July 22, 2008 Zimmer suspended US sales of the
Zimmer Durom Cup citing incorrect implant procedure.
According to Dr. Dorr, a well-paid consultant of
Zimmer, wrote that:
This failure rate has occurred within the first two
years. In the first year the x-rays looked perfect. We
have revised four that did not have any radiolucent
lines or migration (and John Moreland revised one).
These early cups fooled us, but the symptoms were so
classic for a loose implant that we operated the
patients. When we hit on the edge of the cup it would
just pop free. As time goes by the cups begin
developing radiolucent lines. We now have one cup at
two years that has actually migrated a short distance.
It has tilted into varus. We do not believe the
fixation surface is good on these cups. Also there is a
circular cutting surface on the periphery of the cup
that we believe prevents the cup from fully seating. We
stopped using the cup after the first revisions." Read
more about the Zimmer
Durom Hip Implant recall and lawsuits by clicking
Hip Implant Replacement Surgery Class Action Lawsuit
BP Oil Spill Information
Consumer Justice Attorney
Environmental Alert: BP Oil Spill
or Contact Us For Help
Our firm is no longer accepting BP Oil Cases. The
deadline for filing a claim is April 20, 2011. If you
do not file by that date your case or claim may be
forever barred. You can easily file your case even
without a lawyer to protect your rights. There is no
filing fee to file your claim. Filing your case with
the Gulf Coast Claims Facility (GCCF) is not the same
as filing your case in court. If you have any doubt you
should file this form.
Do not delay. Act today to protect your rights if
you have had a personal injury, loss of earnings,
property damage, business loss, or other economic loss
from the Oil Spill.
Click Here For More Information About On How To File
Your BP Oil Spill Claim
Raytheon Class Action Lawsuit
Attorney Joseph Saunders Has
Filed A Class Action Groundwater Contamination
or contact form
Pinellas Park-Attorney Joe Saunders
has filed a class action civil lawsuit against Raytheon
Corporation in Pinellas County Circuit Court today on
behalf of St. Petersburg’s Azalea neighborhood
residents who have been affected by a toxic plume
contaminating their groundwater.
Attorney Saunders was contacted several weeks ago by
a concerned Azalea neighborhood resident. The Raytheon
plant located at 1501 72nd St. North in St. Petersburg
has been leaking toxic chemicals including vinyl
chloride, 1,4-dioxane, and trichloroethylene. The
chemicals have contaminated the groundwater in the
Saunders held a press conference at
AzaleaPark, 1600 72nd
St. North in St. Petersburg on Monday, April
14, 2008 at 3:00pm. Copies of the lawsuit
were available at the press conference and can be downloaded
Saunders & Walker's special mission is the
representation of seriously injured persons and the
representation of families of persons whose lives have
been wrongfully taken by the negligence of others. Our
practice focuses on lawsuits against companies that
manufacture dangerous pharmaceutical products, medical
devices, and medical malpractice. We also represent
persons injured in slip and fall cases, auto accidents,
and general liability cases.
Attorney Joseph H. Saunders founded the law firm
over twenty years ago. Mr. Saunders is Board Certified
Nationally as a Civil Trial Lawyer as well as by the
Florida Board of Specialization and Education. Saunders
has been active in nationwide mass tort litigation,
class actions, and individual cases involving
pharmaceutical drugs such as Fen-Phen, Baycol, Permax,
Avandia, Vioxx and Zyprexa. His practice has also
included cases involving diet supplements such as
Ephedra, Kava Kava and medical devices such as
Medtronic and Guidant Defibrillators, Sulzer hip
implants and Composix Kugel Hernia Mesh Patches. He has
also been involved in consumer product litigation such
as Bausch & Lomb Renu Contact Lens Solution cases
and contaminated food cases including the recent
ConAgra peanut butter recall.
Attorneys Margaret Walker has practiced law for over twenty years.
Darlene Korab R.N., RAC, a registered nurse, has
years of experience in regulatory compliance with major
pharmaceutical companies. She provides and arranges
medical reviews and investigates pharmaceutical
corporate negligence and fraud. Another member of our
team, Peter Schweitzer, M.A., M.Div., is dedicated to
achieving justice for survivors of sexual abuse. These
individuals, combined with our staff of experienced and
dedicated paralegals, use the latest electronic
technology to serve our clients. Our firm contracts
with clients on percentage contingency fees only and
does not bill clients for hourly work.
The firm handles a wide range of cases and is always
open to seeking justice for those wronged by corporate
misconduct and individual negligence or wrongdoing..
Recent taser death leads to lawsuit
filed against taser company, which
marketed the weapons as non-lethal, for
failing to properly warn police
departments and falsely promoting the
product as safe.
Kava Kava Side
In March 2002, the FDA issued a
consumer advisory concerning the
potential for liver damage to those
using Kava Kava and Kava
Kava-containing products have been
associated with liver-related injuries
– including hepatitis, cirrhosis,
and liver failure -- in over 25 reports
of adverse events in other countries.
Four patients required liver
transplants. In the U.S.,
One of the country's leading
manufacturers of eye contact solution
has stopped shipments of its popular
ReNu and MoistureLoc solutions after
investigations have shown the products
can cause a potentially dangerous eye
Your Consumer Justice
As trial attorneys, we represent only injured
people. We don't represent insurance companies or
large corporations. As you can see from the Practice
Areas listed to your left, we have represented numerous
individuals in cases involving harmful products,
dangerous pharmaceutical drugs such as Baycol and Vioxx
and the diet drugs such as Fen-Phen, Redux, and
Most recently, we've represented victims of physical
and sexual abuse against various churches and the
Florida Department of Children and Families.
We take our responsibility to our clients very
seriously. In each practice area, we are committed to
providing them with the best representation possible.
If you or a loved one have suffered a serious injury
or death as a result of someone else's negligence, call
us at 800-748-7115
and Sexual Abuse